iBio (IBIO) News Today $2.92 +0.09 (+3.18%) As of 01/21/2025 Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesInsider TradesSEC Filings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period iBio Announces Successful Closing of Private Placement OfferingOn January 10, 2025, iBio, Inc. (NYSE American: IBIO) announced the completion of a private placement offering, marking an important development for the company. The securities purchase aJanuary 16, 2025 | americanbankingnews.com**January 14, 2025 | americanbankingnews.comiBio Announces New Investments from Board Members and OfficersJanuary 13, 2025 | markets.businessinsider.comiBio expands cardiometabolic, obesity treatment development programJanuary 3, 2025 | markets.businessinsider.comiBio Strengthens Board with Appointment of Two New Independent DirectorsNovember 25, 2024 | finance.yahoo.comOklo Inc. Reports Q3 2024 Financial ResultsNovember 15, 2024 | markets.businessinsider.comiBio Inc. stock remains steady Monday, underperforms marketNovember 11, 2024 | marketwatch.comOhio Senate Results: Bernie Moreno WinsNovember 6, 2024 | nbcnews.comiBio Inc. stock remains steady Monday, still outperforms marketNovember 4, 2024 | marketwatch.comBiopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug DevelopmentsOctober 14, 2024 | uk.finance.yahoo.comWhat channel is Oregon vs. Ohio State on today? Time, TV schedule to watch week 7 gameOctober 12, 2024 | msn.comHow to watch Ohio State vs Oregon college football: TV, Live stream info, kickoff time, game previewOctober 12, 2024 | msn.comStock Market Today: Dow Rises; Chinese Indexes Post Best Week in YearsSeptember 27, 2024 | wsj.comiBio, Inc.: iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateSeptember 21, 2024 | finanznachrichten.deiBio Inc. stock outperforms market despite losses on the daySeptember 16, 2024 | marketwatch.comStock market today: Dow jumps 484 points as US stocks rebound ahead of key inflation reportSeptember 10, 2024 | msn.comInovio Pharmaceuticals, Inc. (INO)August 29, 2024 | finance.yahoo.comiBio Inc. stock remains steady Wednesday, still outperforms marketAugust 28, 2024 | marketwatch.com13F Recap Q2 2024: Klarman, Rosenstein, Miller And MoreAugust 25, 2024 | msn.comiBio Inc. stock rises Friday, still underperforms marketAugust 23, 2024 | marketwatch.comCOSCIENS BIOPHARMA CORP. (ET8.F)August 23, 2024 | finance.yahoo.comiBio Inc. stock remains steady Tuesday, still outperforms marketAugust 20, 2024 | marketwatch.comiBio Inc. stock remains steady Thursday, underperforms marketAugust 15, 2024 | marketwatch.com0JV0.SG,0P00013BY9,0 (0JV0.SG)August 15, 2024 | nz.finance.yahoo.comOptimistic Outlook for ProQR: Solid Financials and Promising Drug Pipeline Justify Buy RatingAugust 9, 2024 | markets.businessinsider.comiBio Inc. stock falls Friday, underperforms marketAugust 2, 2024 | marketwatch.comBuy Rating Justified by Arbutus Biopharma’s Strong Financials and Focused Clinical StrategyAugust 2, 2024 | markets.businessinsider.comTesla’s latest earnings expose chronically weak profitability and an inflated share priceJuly 25, 2024 | msn.comTesla's 2Q Profit Falls 45% to $1.48 Billion as Sales Drop Despite Price Cuts and Low-Interest LoansJuly 25, 2024 | usnews.comiBio, Mesoblast, Kodiak Sciences among healthcare moversMarch 28, 2024 | msn.comMicro-Cap Stock iBio Doubles On Wednesday - Here's WhyMarch 27, 2024 | msn.comiBio partners with AstralBio to develop obesity treatments using AI-driven platformMarch 27, 2024 | proactiveinvestors.comiBio Shares Double After Collaboration Agreement With AstralBioMarch 27, 2024 | marketwatch.comWhy Is iBio (IBIO) Stock Up 125% Today?March 27, 2024 | investorplace.comMega Millions winning numbers for enormous $1.1 billion jackpot on March 26March 27, 2024 | msn.comRon DeSantis signs bill banning social media for kids under 14 in FloridaMarch 27, 2024 | msn.comiBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesMarch 27, 2024 | globenewswire.comiBio Announces $15.0 Million Private PlacementMarch 26, 2024 | globenewswire.comiBio Sells Preclinical PD-1 Antagonist Antibody Program to OtsukaFebruary 26, 2024 | marketwatch.comiBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaFebruary 26, 2024 | globenewswire.comiBio IncFebruary 22, 2024 | money.usnews.comHow to capture screenshots on your Mac: A step-by-step guideFebruary 13, 2024 | msn.comTrain hits, kills person who trespassed on tracks in HaywardFebruary 12, 2024 | msn.comUsher's Wife Responds To Alicia Keys Super Bowl DramaFebruary 12, 2024 | msn.comiBio Announces Participation in 23rd Annual PepTalk ConferenceJanuary 16, 2024 | finance.yahoo.comiBio Amends and Extends Maturity of Credit AgreementDecember 26, 2023 | finance.yahoo.comLooking Into iBio's Recent Short InterestDecember 8, 2023 | benzinga.comIBio Shares Drop 43% After Public OfferingDecember 5, 2023 | marketwatch.comiBio prices 2.25M shares at $2.00 in public offeringDecember 5, 2023 | msn.comIBio Prices Public Offering Of 2.25 Mln Shares At $2/shrDecember 5, 2023 | markets.businessinsider.com Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address IBIO Media Mentions By Week IBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IBIO News Sentiment▼0.790.63▲Average Medical News Sentiment IBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IBIO Articles This Week▼10▲IBIO Articles Average Week Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EDIT News Today ABOS News Today CRDL News Today LPTX News Today MGX News Today HLVX News Today ME News Today TARA News Today DBVT News Today ORMP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEMKT:IBIO) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.